# Bimzelx

NDC: 50474-780
Generic name: bimekizumab
Labeler / Manufacturer: UCB, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20231017

FDA application: BLA761151

## Active ingredients

- BIMEKIZUMAB: 160 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50474-780"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50474-780
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=26b88358-871f-4c80-9d80-b2fb16477f81